Wyatt Investment Research login

 
Forgot password? Not a Subscriber? - Start Here
 
 
HOMEWEEKLY NEWSLETTERMODEL PORTFOLIOSPECIAL REPORTSVIDEO UPDATESCUSTOMER SERVICE
 
 

Tag - Amcc

 

 
Claire Caldwell

DryShips, Eagle Bulk Shipping and Sierra Wireless lead small-cap volume in pre-market

DryShips Inc. (Nasdaq:DRYS), Eagle Bulk Shipping Inc. (Nasdaq:EGLE) and Sierra Wireless Inc. (Nasdaq:SWIR) are among the most actively traded companies in Friday's trading among companies with market capitalizations under $1 billion.

Also included among the results: AMAG Pharmaceuticals Inc. (Nasdaq:AMAG), James River Coal Co. (Nasdaq:JRCC), Applied Micro Circuits Corp. (Nasdaq:AMCC), Acme Packet Inc. (Nasdaq:APKT), S1 Corp. (Nasdaq:SONE) and Force Protection Inc. (Nasdaq:FRPT).
[ More » ]
Will Atkinson

Acorda Therapeutics, Jos A Bank Clothiers and OmniVision Technologies lead small-cap volume in pre-market

Acorda Therapeutics Inc (Nasdaq:ACOR), Jos A Bank Clothiers Inc (Nasdaq:JOSB) and OmniVision Technologies Inc (Nasdaq:OVTI) are among the most actively traded companies in Monday's trading among companies with market capitalizations under $1 billion.

Canadian Solar Inc (Nasdaq:CSIQ), Applied Micro Circuits Corp (Nasdaq:AMCC) and Iconix Brand Group Inc (Nasdaq:ICON) are also among the most actively traded companies.

Here are the most actively traded companies among small caps:
[ More » ]
Alex Alexandrov

Russell 2000 stays flat

April 23 (SmallCapInvestor.com) – The Dow and the Russell 2000 are moving sideways this morning as investors consolidate their gains after Friday’s rally.  Among small caps, Gentex Corporation (Nasdaq: GNTX) beat analysts’ earnings estimates, while shares of Applied Micro Circuits Corporation (Nasdaq: AMCC) fell on news of lower quarterly revenue.

At 11:41 AM the Russell 2000 was down 0.44 points, or 0.05 percent, to 828.42.  The Dow Jones Industrial Average had lost 1.62 points, or 0.01 percent, to 12,960.36.
[ More » ]
Alex Alexandrov

Pre-market: NMT Medical gets study approval

Shares of Boston-based medical technology company NMT Medical, Inc. (Nasdaq: NMTI) have moved up on news this morning that it received conditional approval from the U.S. Food and Drug Administration for its study of stroke and transient ischemic attack.  NMT Medical plans to involve 800 patients in the study.  Shares are up $0.09, or 0.62%, to $14.55.
[ More » ]